Institutional Cluster

MGNX

MACROGENICS INC
BULLISH
Impact 6/10
Horizonweeks Processed7mo ago
Institutional cluster: 3 buyers, 0 sellers (bullish)
Actionable Insight ▲ Bullish

The absence of institutional selling and strong buying from mega-passive firms may signal growing confidence in MacroGenics' pipeline or upcoming catalysts. Traders should monitor for near-term clinical updates or partnerships as potential triggers.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
MGNX ▲ +130.41% at T+60d
LONG call ✓ call won +130.41% · α vs SPY +121.09% · entry $1.94 → $4.47
Entry anchored
Feb 27, 03:59 PM ET
via exchange tick
T+1d
-2.06%
call -2.06% · α -1.15%
$1.90
settled 7mo ago
T+5d
+21.65%
call +21.65% · α +22.86%
$2.36
settled 7mo ago
T+20d
+42.27%
call +42.27% · α +50.21%
$2.76
settled 6mo ago
T+60d
+130.41%
call +130.41% · α +121.09%
$4.47
settled 4mo ago

Executive Summary

Three major institutional investors — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in MacroGenics (MGNX) during Q4 2024, collectively adding $2.8M in new holdings with no institutional selling observed. The cluster is driven by large passive managers doubling down on the stock, suggesting growing institutional interest despite the company's small market cap of $126M.

Key Financial Metrics

Direction
accumulating
Buy Value
$2.8M
Net Flow
$2.8M

Institutional Positions

Net institutional flow: $2.8M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan StanleyDOUBLED+245.3%$3.6M$2.5M
UBSADD+60.3%$552.0K$204.0K
Wells FargoADD+45.4%$97.0K$29.0K

Key Facts

  • Morgan Stanley doubled its position, increasing value by $2.5M (from $1.1M to $3.6M)
  • Wells Fargo and UBS added $29K and $204K respectively
  • No institutional sellers reported in the quarter
  • Total net buying: $2.8M across three mega-passive institutions

Financial Impact

3 institutions accumulated $2.8M in new positions, increasing total institutional holdings by 207% quarter-over-quarter

floatinstitutional ownershipliquidity

Risk Factors

  • All buyers are passive managers, which may reflect index inclusion or rebalancing rather than fundamental conviction
  • Small market cap makes the stock vulnerable to volatility if institutions reverse

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MGNX-2024-Q4
11 reports for MGNX
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +32.85%Apr 8, 2026
Filters
Rows
Reports for MGNX — sortable, filterable
TypeNow
Jul 8, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$4.57 $4.01▼ −12.25%▼ −14.50%—
Jul 2, 2026
13w ago
Press Release
BULLISH ★ 6/10
$4.71 $3.78▼ −19.75%▼ −19.33%—
Jun 12, 2026
16w ago
Institutional Cluster
MIXED ★ 6/10
$3.96 $4.33▲ +9.34%▲ +7.56%—
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$4.01 $4.57▲ +13.97%▲ +12.07%—
May 13, 2026
20w ago
8-K
BULLISH ★ 7/10
$4.16 $3.96▼ −4.81%▼ −3.95%—
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$3.52 $3.87▲ +9.94%▲ +11.67%—
May 11, 2026
20w ago
Press Release
MIXED ★ 6/10
$3.52 $3.87▲ +9.94%▲ +11.67%—
Apr 8, 2026
25w ago
8-K
BULLISH ★ 7/10
$3.44 $3.01▼ −12.50%▼ −20.07%—
Apr 8, 2026
25w ago
Press Release
BULLISH ★ 7/10
$3.44 $3.01▼ −12.50%▼ −20.07%—
Apr 8, 2026
25w ago
DEFA14A
NEUTRAL ★ 2/10
$3.44 $3.01▼ −12.50%▼ −20.07%—
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Feb 28, 2026